NCT01805583

Brief Summary

Evidence-based clinical treatments for common mental disorders, such as CBT and/or pharmacotherapy, have resulted in significant and sustained improvement in clinical symptoms. However, the individual-focused treatments rarely have sickness absence as a target of intervention or evaluate work-related outcomes, such as return to work. A recent review of the evidence for managing stress at work showed that individual interventions give effects on mental health measures but did not impact absenteeism at work. The purpose of this study is to examine the efficacy and cost-effectiveness of two different rehabilitation models, one based on psychotherapy and the other on workplace-interventions, when these are offered as standalone interventions and in combination for patients with adjustment, anxiety and depressive disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
352

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2013

Completed
10 days until next milestone

Study Start

First participant enrolled

March 1, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 6, 2013

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

March 21, 2016

Status Verified

March 1, 2016

Enrollment Period

2.6 years

First QC Date

February 19, 2013

Last Update Submit

March 18, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Return to work

    Primary outcome measure is RTW based on register data on number of sick leave days from the National Insurance Office (NIO), self-reported data regarding short-term absence (periods of less than 14 days, that is not registered at NIO) and self-reported work ability according to scores in the Work Ability Index (WAI). The primary outcome will be reported as change over time from inclusion and at 6, 12, 24 and 60 months.

    at 6, 12, 24 and 60 months

Secondary Outcomes (5)

  • Changes in symptom severity of depression

    at 6, 12, 24 and 60 months

  • Changes in symptom severity of anxiety

    at 6, 12, 24 and 60 months

  • Changes in score of burnout symptoms

    at 6, 12, 24 and 60 months

  • Changes in scores of General function

    at 6, 12, 24 and 60 months

  • Changes in scores of general satisfaction with life

    at 6, 12, 24 and 60 months

Study Arms (4)

ACT

EXPERIMENTAL

The ACT intervention consists of 6 manual-based face-to-face sessions and internet-based homework modules. The manual is based on the six core processes in the ACT-model: acceptance, mindfulness, defusion, self as context, values and committed action.

Other: Acceptance and Commitment Therapy (ACT)

WPI

EXPERIMENTAL

This interventions aims at the facilitation of dialogue between the participant and the workplace through a series of steps consisting of individual interviews with the participant and his/her nearest supervisor and a so called "convergence dialogue meeting" in order to agree upon short- and long-term solutions.

Other: workplace intervention (WPI)

ACT and WPI

EXPERIMENTAL

The study participants receive both ACT and WPI. The ACT intervention consists of 6 manual-based face-to-face sessions and internet-based homework modules. The manual is based on the six core processes in the ACT-model: acceptance, mindfulness, defusion, self as context, values and committed action. WPI aims at the facilitation of dialogue between the participant and the workplace through a series of steps consisting of individual interviews with the participant and his/her nearest supervisor and a so called "convergence dialogue meeting" in order to agree upon short- and long-term solutions.

Other: Acceptance and Commitment Therapy (ACT)Other: workplace intervention (WPI)

Control group

NO INTERVENTION

Treatment as usual (TAU) which means that the participant continues in ordinary health care and does not receive interventions other than the initial assessment.

Interventions

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Employment grade at 50% minimum. On Sick-leva for at least 1-12 moths due to adjustment, anxiety or depressive disorders.

You may not qualify if:

  • Patients with addiction disorders, schizophrenia, psychotic disorders high suicidal risk, bipolar disorder, severe depression or generalized anxiety disorder. Patients on current psychotherapy. Patients that do not speak and write Swedish.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FORUM-Centrum för psykiatrforskning, Danderyds sjukhus

Stockholm, 182 88, Sweden

Location

Related Publications (1)

  • Finnes A, Ghaderi A, Dahl J, Nager A, Enebrink P. Randomized controlled trial of acceptance and commitment therapy and a workplace intervention for sickness absence due to mental disorders. J Occup Health Psychol. 2019 Feb;24(1):198-212. doi: 10.1037/ocp0000097. Epub 2017 Sep 28.

MeSH Terms

Conditions

Adjustment DisordersAnxiety DisordersDepression

Interventions

Acceptance and Commitment Therapy

Condition Hierarchy (Ancestors)

Trauma and Stressor Related DisordersMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Anna Nager, MD, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

February 19, 2013

First Posted

March 6, 2013

Study Start

March 1, 2013

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

March 21, 2016

Record last verified: 2016-03

Locations